BAXTER

History

Year	Detail
1931	Dr. Ralph Falk and Don Baxter launched the Don Baxter Intravenous Products Corporation to manufacture the prepared IV solutions.
1935	Don Baxter Introduced the TRANSFUSO-VAC container for blood collection and storage, which made blood banking practical and allowed storage for up to 21 days.
1941	The company launched a PLASMA-VAC container, which allows plasma to be separated from whole blood for storage.
1948	Baxter Intravenous Products Corp. launched an unbreakable plastic container for blood storage.
1950	The company opened the second U.S. manufacturing facility in Cleveland, Mississippi.
1954	The company expanded internationally by opening an office in Belgium.
1960	Baxter Introduced the first peritoneal dialysis (PD) solution. It filters waste from the blood of people in renal failure through their peritoneal membrane rather than an external dialyzer.
1970	The company Introduced Viaflex, the first flexible, plastic IV container. This allowed infusions within a closed system, which reduced the chance for contamination.
1985	Baxter acquired American Hospital Supply Corporation, a healthcare distribution company.
1991	The company launched the Interlink IV Access System, introducing the first "needleless" system for IV therapy.
1994	It Launched Homechoice, an automated peritoneal dialysis (APD) system and opened a plant in Singapore to make peritoneal dialysis solutions for the Asian market.
1998	Baxter acquired Ohmeda's Pharmaceutical Products Division, and Also the company introduced the first triple-chamber flexible container for total parenteral nutrition and gained approval for our Tisseel product, the first fibrin sealant in the U.S.
2005	Baxter developed the world's first operating room lights with Light Emitting Diode (LED) technology, providing optimal and consistent lighting for surgeons and clinicians.
2007	The company introduced V-Link, the first IV connector with an antimicrobial coating.
2012	It acquired Sigma, a manufacturer of smart infusion pumps, and Synovis Life Technologies Inc. a microsurgery products company.
2016	Baxter launched Numeta G13E, the only triple-chamber, ready-to-use parenteral nutrition system approved for preterm infants. Also, HDx enabled by our Theranova is a new dialysis therapy pioneering for patients with end-stage renal disease.
2018	It launched the Kaguya APD system in Japan, reflecting local needs and demographics and making it a viable treatment option for renal patients.
2019	Baxter launched Myxredlin, the ready-to-use insulin for IV infusion, capping off the addition of seven premixed drugs.